| ENANTA PHARMACEUTICALS INC (ENTA) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | Q4-CY2013 | |
| Balance Sheet Date | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Dec-31 | 2021-Sep-30 | 2021-Jun-30 | 2021-Mar-31 | 2020-Dec-31 | 2020-Sep-30 | 2020-Jun-30 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | 2018-Mar-31 | 2017-Dec-31 | 2017-Sep-30 | 2017-Jun-30 | 2017-Mar-31 | 2016-Dec-31 | 2016-Sep-30 | 2016-Jun-30 | 2016-Mar-31 | 2015-Dec-31 | 2015-Sep-30 | 2015-Jun-30 | 2015-Mar-31 | 2014-Dec-31 | 2014-Sep-30 | 2014-Jun-30 | 2014-Mar-31 | 2013-Dec-31 | |
| Fiscal Period | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2022 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | Q1-FY2017 | Q4-FY2016 | Q3-FY2016 | Q2-FY2016 | Q1-FY2016 | Q4-FY2015 | Q3-FY2015 | Q2-FY2015 | Q1-FY2015 | Q4-FY2014 | Q3-FY2014 | Q2-FY2014 | Q1-FY2014 | |
| Price to Sales | 5.36x | 3.92x | 2.47x | 1.82x | 1.83x | 3.24x | 3.80x | 5.07x | 2.69x | 2.98x | 5.58x | 10.40x | 11.77x | 12.46x | 10.95x | 15.97x | 16.41x | 11.81x | 9.16x | 10.58x | 8.34x | 7.51x | 6.69x | 5.82x | 6.49x | 5.76x | 7.51x | 7.93x | 5.74x | 8.01x | 10.37x | 9.36x | 8.60x | 8.70x | |||||||||||||||
| Price to Book | 5.41x | 3.96x | 2.02x | 1.26x | 1.09x | 1.70x | 1.83x | 2.22x | 1.03x | 1.09x | 1.89x | 3.13x | 3.21x | 3.34x | 2.90x | 4.08x | 3.97x | 2.87x | 2.13x | 2.29x | 1.87x | 2.02x | 2.09x | 2.11x | 2.53x | 2.55x | 3.70x | 4.25x | 3.20x | 4.20x | 6.19x | 4.65x | 3.53x | 2.96x | |||||||||||||||
| Price to Earnings | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 425.05x | 43.25x | 36.05x | 25.47x | 25.68x | 23.83x | 15.85x | 22.99x | 27.56x | 29.63x | 32.62x | 50.48x | |||||||||||||||
| Price to Unlevered FCF | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 162.91x | 33.85x | 29.46x | 25.39x | 17.90x | 19.42x | ||||||||||||||||||||||
| Debt to Asset Ratio | .77x | .74x | .71x | .68x | .66x | .63x | .60x | .55x | .53x | .52x | .17x | .13x | .14x | .12x | .12x | .13x | .09x | .07x | .07x | .06x | .06x | .06x | .05x | .06x | .06x | .05x | .05x | .06x | .05x | .05x | .06x | .07x | .08x | .05x | .05x | .04x | .04x | .05x | .05x | .05x | .04x | .04x | .09x | .10x | .04x | .04x | .06x | .04x | |
| Current Ratio | 4.21x | 5.00x | 5.29x | 5.47x | 5.21x | 4.92x | 6.43x | 6.25x | 6.73x | 6.58x | 8.43x | 12.33x | 10.45x | 13.59x | 11.12x | 8.63x | 8.82x | 11.22x | 16.09x | 19.35x | 18.08x | 17.29x | 20.63x | 23.02x | 17.77x | 22.01x | 20.68x | 18.70x | 23.74x | 24.23x | 17.86x | 12.88x | 11.33x | 18.53x | 20.82x | 34.84x | 29.43x | 25.27x | 20.24x | 19.23x | 25.45x | 23.61x | 8.98x | 9.32x | 22.75x | 26.17x | 22.48x | 36.75x | |